LBA: Oral Vitamin C Supplementation for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions Might Improve OS

Watch Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, discuss her late-breaking abstract, which was just presented at the Late-Breaking Oral Session at EHA 2024. The study shows that there is significant potential for vitamin C supplementation to improve OS in patients with low-risk myeloid malignancies and precursor diseases.